A detailed history of Agf Management LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Agf Management LTD holds 3,234,622 shares of BSX stock, worth $323 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
3,234,622
Previous 4,747,292 31.86%
Holding current value
$323 Million
Previous $479 Million 27.45%
% of portfolio
1.68%
Previous 2.75%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$89.7 - $107.41 $136 Million - $162 Million
-1,512,670 Reduced 31.86%
3,234,622 $347 Million
Q1 2025

May 12, 2025

SELL
$89.38 - $106.18 $4.45 Million - $5.29 Million
-49,829 Reduced 1.04%
4,747,292 $479 Million
Q4 2024

Feb 07, 2025

SELL
$83.62 - $91.5 $10 Million - $11 Million
-120,000 Reduced 2.44%
4,797,121 $428 Million
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $5.08 Million - $5.85 Million
69,590 Added 1.44%
4,917,121 $412 Million
Q2 2024

Aug 07, 2024

SELL
$67.33 - $77.71 $460,941 - $532,002
-6,846 Reduced 0.14%
4,847,531 $373 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $255,801 - $304,741
-4,441 Reduced 0.09%
4,854,377 $332 Million
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $1.02 Million - $1.21 Million
-20,973 Reduced 0.43%
4,858,818 $281 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $46.7 Million - $50.8 Million
929,763 Added 23.54%
4,879,791 $258 Million
Q2 2023

Aug 09, 2023

BUY
$49.72 - $54.64 $82.1 Million - $90.2 Million
1,651,426 Added 71.84%
3,950,028 $214 Million
Q1 2023

May 03, 2023

BUY
$45.09 - $50.03 $102 Million - $113 Million
2,262,088 Added 6195.13%
2,298,602 $115 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $1.44 Million - $1.72 Million
36,514 New
36,514 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $143B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.